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Abstract
A series of analogues of Pseudonocardia sp. natural products were synthesized, which have been reported to possess potent anti-
bacterial activity against Helicobacter pylori and induce growth defects in Escherichia coli and Staphylococcus aureus. Taking
inspiration from a methodology used in our total synthesis of natural products, we applied this methodology to access analogues
possessing bulky N-substituents, traditionally considered to be challenging scaffolds. Screening of the library provided valuable
insights into the structure–activity relationship of the bacterial growth defects, and suggested that selectivity between bacterial
species should be attainable. Furthermore, a structurally related series of analogues was observed to inhibit production of the viru-
lence factor pyocyanin in the human pathogen Pseudomonas aeruginosa, which may be a result of their similarity to the Pseudomo-
nas quinolone signal (PQS) quorum sensing autoinducer. This provided new insights regarding the effect of N-substitution in PQS
analogues, which has been hitherto underexplored.
Introduction
The quinolone core has long been implemented in structures
possessing formidable activity in a broad range of fields, includ-
ing antibiotics, bacterial signalling and iron metabolism [1].
Structural optimisation of quinolones possessing intriguing
properties can lead to the discovery of important drug classes,
as demonstrated by the fluoroquinolone antibiotics, which were
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Figure 1: A family of quinolone natural products 1–8, which were first isolated from Pseudonocardia sp. CL38489 by Dekker et al. [3], shown along-
side the structure of the Pseudomonas quinolone signal (PQS), a key autoinducer used in quorum sensing signalling by the human pathogen
Pseudomonas aeruginosa, and 2-heptyl-4(1H)-quinolone (HHQ), the biosynthetic precursor of PQS.
inspired by the observation of an antibacterial quinolone side-
product generated during the synthesis of the antimalarial
chloroquine [2].
Given this high potential for the discovery of useful chemical
entities, we have recently been engaged in research regarding a
family of quinolone natural products which are produced by the
actinomycete Pseudonocardia sp. CL38489, and were first iso-
lated by Dekker et al. (1–8, Figure 1) [3]. The authors noted the
potent antibacterial activity of these compounds against Heli-
cobacter pylori, which is responsible for the generation of nu-
merous digestive disorders [4]. Furthermore, with the presence
of a lipophilic chain in the 2-position, there is a structural
resemblance to the Pseudomonas quinolone signal (PQS), and
its biosynthetic precursor 2-heptyl-4(1H)-quinolone (HHQ),
which are vital to the cooperative behaviour of the human
pathogen Pseudomonas aeruginosa via quorum sensing (QS).
This is a means by which bacteria alter their phenotype in
response to changes in population density, regulating virulence
and biofilm formation when most impactful to the host organ-
ism [5]. This process is mediated by signalling molecules such
as PQS, and natural product structures 1–8 analogous to PQS
may provide interspecies QS-modulator chemical probes. It has
been proposed that such a strategy may perturb bacterial viru-
lence and pathogenicity associated with QS, thus conferring a
therapeutic benefit, without applying a selection pressure for
resistance [6]. Whilst recent experiments suggest that resis-
tance may still emerge, it has been proposed that this develop-
ment should be limited under certain conditions [7].
We wished to investigate the potential of 1–8 to modulate QS in
P. aeruginosa, however, the compounds are available in only
trace amounts from natural sources [3], and so we embarked on
the total synthesis of the compounds. We first developed a
strategy which constructed natural products 1–4 by uniting the
quinolone cores with the side chain by means of an sp2–sp3
Suzuki–Miyaura coupling reaction [8]. Whilst these com-
pounds unfortunately provided no modulation of PQS quorum
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Scheme 1: Proposed use of the chemistry developed towards the total synthesis of 5 and 6 for generation of natural product analogues. Modular
coupling of alkynes 10 and amines 12 with commercially available acid chloride 9 was proposed to give 1,2-disubstituted quinolones 14.
screening (as determined using a heterologous Escherichia coli
reporter system [9]), an intriguing effect upon the growth of
E. coli and Staphylococcus aureus was noted, which showed an
extended lag phase in response to the compounds (except 4,
which was inactive towards E. coli. It should be noted that in
this previous publication, the graphical data for compounds 3
and 4 was erroneously switched). It is tentatively proposed that
this is as a result of disruption of electron transport, as the com-
pounds bear resemblance to the menaquinones which are used
by bacteria for this purpose [10]. Following on from this, we
recently reported a divergent strategy which granted access to
remainder of the natural products 5–8, alongside offering more
efficient synthesis of 1 and 4 [11]. Allylic alcohols 5 and 6 were
accessed from a mutual precursor (constructed using methodol-
ogy adapted from that reported by Bernini et al. [12]) using an
acid-catalysed transposition, whilst 4, 7 and 8 were derivatised
from 1.
In this current work, we turn to the further elucidation of the bi-
ological activity of this class of compounds. In order to gain ad-
ditional insight into the associated structure–activity relation-
ships (SAR), it was desired to generate analogues of the natural
products. The chemistry developed towards the allylic alcohols
5 and 6, outlined in Scheme 1, seemed ideal to this end. A range
of alkynes 10 could undergo Sonogashira coupling with the
commercially available acid chloride 9. The resultant ynones 11
could then undergo conjugate addition with primary amines 12,
which following metal-catalysed cyclisation would give 1,2-
disubstituted quinolones 14.
Upon the successful synthesis of analogues of the form 14, bio-
logical evaluation of these and the natural products 1, 4 and 5–7
(synthesised during our previous study [11]) would then be
possible. In particular, it was desired to further probe the
intriguing growth defects which had been observed for natural
products 1–4 in E. coli and S. aureus. Furthermore, exploration
of any effect on QS of the analogues 14 would be valuable, as
to our knowledge studies on the SAR of PQS analogues have
not yet thoroughly assessed substitution at the 1-position of the
quinolone system [13]. This is perhaps as a result of direct
alkylation at this position being very challenging, with low
yields and poor O- vs N-selectivity being encountered, particu-
larly with a sterically demanding substituent present in the
2-position [14,15].
As a measure of modulation of QS in P. aeruginosa, it was
desired to measure the amount of pyocyanin produced by bacte-
rial cultures after treatment with the compounds. This virulence
factor is known to be under the regulation of PQS signalling
system, and is capable of disrupting many important biochem-
ical processes [16]. This leads to numerous deleterious effects
on human cells, including inhibited respiration and ciliary
action [17]. These effects allow pyocyanin to play a critical role
in infection; indeed, mutant P. aeruginosa strains which are
unable to produce pyocyanin have been shown to be unsuccess-
ful in infecting the lungs of mice [18]. Being able to prevent the
production of pyocyanin could therefore be of great therapeutic
benefit.
Results and Discussion
In the implementation of the strategy outlined in Scheme 1,
alkynes 10a and 10b were first subjected to Sonogashira cou-
pling with commercially available acid chloride 9 according to
the previously reported conditions (Scheme 2) [12]. These
alkynes were chosen so as to allow access to valuable SAR data
regarding the side chain of the natural products 1–8. Commer-
cially available alkyne 10a would ultimately lead to a simple
saturated side chain of the same length as that observed natu-
rally, whilst 10b (itself synthesised according to a literature pro-
cedure [19]) would provide analogues possessing a truncated
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Scheme 2: Sonagashira coupling of alkynes 10a and 10b with commercially available acid chloride 9 to give ynones 11a and 11b.
Scheme 3: Conjugate addition of primary amines 12a–f with ynones 11a and 11b. aFollowing concentration in vacuo, further purification using silica
gel flash chromatography was required.
prenyl-type substituent. In the event, ynone 11a was obtained
with good yield, however, a poorer yield resulted for 11b,
which was attributed to difficulties in obtaining its precursor
10b with high purity which stemmed from its volatility.
These ynones were then subjected to a conjugate addition with
an assortment of primary amines 12a–f (Scheme 3). The reac-
tions proceeded with excellent yield in all cases, with aliphatic
and aromatic moieties well tolerated. Given the high volatility
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Table 1: Optimisation of conditions for the cyclisation of 13ad to natural product analogue 14ad.
entry conditions result
1 Cs2CO3, Pd2dba3, P(2-furyl)3, toluene, 100 °C, 24 h [20] complex mixturea
2 KOt-Bu, dioxane, 90 °C, 24 h [21] 13%b
3 CuI, DMEDA, NaOt-Bu, DMSO, 80 °C, 2 h [12] 22%b
aAs determined by LCMS and 1H NMR analysis of the crude reaction product. bIsolated yield.
of most of the amine starting materials, the products 13 were in
general analytically pure following concentration in vacuo of
the reaction mixture. However, use of higher boiling-point
amines necessitated purification by flash column chromatogra-
phy, which may account for the slightly lower yields in these
cases (13ad and 13ae).
With the compounds 13 now in hand, their cyclisation to the
desired analogues 14 was explored. However, whilst the condi-
tions which had proved successful in the total synthesis of
natural products 5 and 6 proved satisfactory in most cases, some
optimisation was required for substrates possessing unsaturated
functionality attached to the amine (Table 1). When the palla-
dium-catalysed conditions were employed [20], a complex mix-
ture resulted, from which no product could be obtained
(Table 1, entry 1). Meanwhile, use of base-induced SNAr-type
conditions allowed a small amount of product to be isolated
(Table 1, entry 2) [21], but copper-catalysed conditions offered
a higher yield (Table 1, entry 3) [12]. This behaviour stands in
contrast to that noted for substrates bearing an alkyl substituent
in our previous study, for which these copper-catalysed condi-
tions resulted in dimerization [11].
Following the discovery of this substrate-dependent dichotomy
with respect to optimal reaction conditions, the entire library of
compounds was successfully cyclised. Whilst the yields ranged
from low to moderate (Scheme 4), sufficient quantities were ob-
tained to facilitate biological screening. It appeared that bulkier
N-substituents (e.g., 14ae) resulted in lower yields than less
bulky derivatives (e.g., 14bf), underlining the importance of
steric factors during cyclisation. Interestingly, the allyl-substi-
tuted substrates 13ab and 13bb underwent an isomerisation
under the reaction conditions, with the double bond moving into
conjugation with the amine to give inseparable mixtures of en-
amine-type products 14ab and 14bb. Given the likely
hydrolytic instability of synthetic precursors possessing an en-
amine moiety, these compounds would likely be highly chal-
lenging to synthesise by other means. However, it is proposed
that the involvement of the nitrogen lone-pair in the aromaticity
of the quinolone system attenuates the susceptibility of 14ab
and 14bb towards hydrolysis.
Intriguingly, the employment of an excess of DMEDA in the
Cu-catalysed cyclisation of 13bb generated 14bg as a side-
product, which represents another interesting analogue for bio-
logical study (Scheme 5). This may putatively result from the
displacement of the allylamine in 13bb by the DMEDA ligand,
followed by heterocyclisation with concomitant N–>N’ methyl
transfer.
With the library of natural products and analogues in hand, our
attention turned to their biological activity. It was desired to
further explore the growth defects which had been previously
noted for natural products 1–4 against E. coli and S. aureus, and
so these species were grown in the presence of the compounds.
The results for E. coli ESS are shown in Figure 2, split into the
natural product series, the series of analogues with a saturated
side chain, and the truncated series of analogues. As can be seen
in Figure 2A, natural product 1 resulted in slowed bacterial
growth whilst 4 elicited no such effect, consistent with our
previous observations (although the later recovery in popula-
tion in the presence of 4 was less pronounced in the present
case) [8]. Meanwhile, 5 appeared to show a moderate growth-
slowing effect, which when compared to the stronger effect pre-
viously observed for 3, demonstrates that oxidation of the
geranyl side chain is deleterious to the biological effect under
investigation. The regioisomeric 6 showed a very small effect,
further showing the lack of tolerance of the effect towards side-
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Scheme 4: Cyclisation of precursors 13 to natural product analogues 14 using palladium- or copper-catalysed conditions. Yields quoted are isolated.
a13ab used as starting material, E/Z ratio = 29:71 based on 1H NMR data. b13bb used as starting material, E/Z ratio = 15:85 based on 1H NMR data.
Scheme 5: Use of an excess of DMEDA in the Cu-catalysed cyclisation of 13bb resulted in the generation of 14bg as a side-product,
alongside 14bb.
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Figure 2: Growth of E. coli ESS with time in the presence of 200 μM of
each compound. A) Natural product series. B) Saturated analogue
series. C) Truncated analogue series. Neg = negative control (DMSO
blank), Pos = positive control (gentamicin). Experiments were carried
out in triplicate, with the exception of 7, for which there was insufficient
material for repeats. Error bars refer to standard deviation.
chain oxidation. Finally, neither replacement of the N-Me of 4
with the methylthiomethylene substituent of 7, nor epoxidation
of 4’s side chain to give 8, offered any improvement in the bio-
logical activity. The result for 8 is particularly intriguing, as this
natural product was noted to have the strongest effect upon the
growth of H. pylori in the study by Dekker et al., which may
imply that these compounds are acting through different mecha-
nisms upon each bacterial species. Next, considering Figure 2B
and C, we see that none of the analogues were capable of
affecting the growth of E. coli, further demonstrating the impor-
tance of the geranyl side for biological activity against this
species. This observation is particularly striking for analogue
14bf, which possesses an identical quinolone core structure to
natural product 3, which was previously shown to be active.
Figure 3: Growth of S. aureus 25923 with time in the presence of
200 μM of each compound. A) Natural product series. B) Saturated an-
alogue series. C) Truncated analogue series. Neg = negative control
(DMSO blank), Pos = positive control (gentamicin). Experiments were
carried out in triplicate, with the exception of 7, for which there was
insufficient material for repeats. Error bars refer to standard deviation.
Meanwhile, Figure 3 shows the data for S. aureus 25923, which
is split into the same three series as before. Considering the
natural products (Figure 3A), we see that both 1 and 4 resulted
in a slowing of growth consistent with that reported previously,
although the effect for 1 was less pronounced in the present
case, operating for only the first three hours [8]. Whilst most of
the other natural products appeared to show only slight effects,
moderate activity was observed for 7, which stands in an inter-
esting contrast to the inactivity of this compound against E. coli.
This implies that the structural requirements for optimal activi-
ty differ between the species, a conclusion which is further
bolstered by the results for the saturated series of analogues
shown in Figure 3B. Whilst these compounds were completely
inactive against E. coli, in this case a strong effect was ob-
served, which for 14aa, 14ab and 14ac was comparable to the
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Figure 4: OD520 (absorption corresponding to pyocyanin) normalised
by the culture population (measured by OD600) for cultures of
P. aeruginosa PA01 grown in the presence of concentrations of
200 μM of natural products and analogues after 8 hours. WT = wild
type, no treatment added. DMSO = treated with DMSO blank. The ex-
periment for 7 was not performed due to lack of material. The most
promising results were replicated once to ensure validity, as shown by
error bars.
positive gentamicin control over the timescale of concern.
These results show the high efficacy of the saturated side chain
against S. aureus, however, considering the data for 14ad and
14ae, we can observe that adding bulky aromatic moieties to the
N-substituent results in reduced activity, with smaller alkyl
groups in this position instead being optimal. Finally, the trun-
cated series of analogues appeared to show only small effects
upon the growth of S. aureus (Figure 3C).
Attention then turned to the ability of the compounds to modu-
late P. aeruginosa PA01 QS, as measured by the production of
the virulence factor pyocyanin. Bacterial cultures were grown
for eight hours in the presence of each compound, followed by
extraction of the pyocyanin under acidic conditions [22]. This
was then quantified by measurement of the OD520, which corre-
sponds to absorption by the toxin. The results are shown in
Figure 4, normalised by the bacterial density as measured by
OD600 (no significant effect on the overall growth of the
bacteria was observed for any of the compounds, see Support-
ing Information File 1 for details). The most promising results
were replicated to ensure validity (due to the large amount of
chemicals required for the assay, it was not practical to perform
this for every compound). Of the natural products, only 4
seemed to show attenuation of pyocyanin production relative to
the negative control. Meanwhile, whilst the truncated series of
analogues appeared to lack activity, a marked reduction in
pyocyanin production was noted for the compounds possessing
a linear octanyl side chain. We speculate that this is due to
the similarity to the heptanyl chain present in the native
PQS ligand. This observation is highly intriguing, as HHQ
(Figure 1), which differs from these analogues only by the lack
of an N-substituent and a slightly shortened side chain, is
known to activate P. aeruginosa QS (although it is incapable of
inducing full pyocyanin expression) [23]. It would therefore
appear that this inhibitory activity is likely due to the N-substi-
tution, an avenue which has been to our knowledge underex-
plored in the SAR analysis of PQS and HHQ. In particular, ana-
logues possessing smaller N-substituents (14aa, 14ab and 14ac)
appeared to elicit a stronger effect than those possessing larger
aromatic moieties (14ad and 14ae).
Conclusion
We have reported the synthesis of structural analogues of a
family of 4-quinolone Pseudonocardia sp. natural products,
which encompassed variation of both the side chain and N-sub-
stituent. This represented an extension of the chemistry which
we employed towards the natural products, utilising sequential
Sonogashira coupling, high-yielding conjugate addition, and
metal-catalysed cyclisation. A dichotomy in the optimal condi-
tions for the final step was discovered, depending on the nature
of the N-substituent. These analogues were then tested, together
with a number of previously synthesised natural products, for
their ability to bring about an intriguing “growth-slowing”
effect towards certain species of bacteria. Whilst the presence of
a geranyl side chain was shown to be vital for strong activity in
E. coli, analogues possessing a saturated side chain exhibited
marked inhibition of S. aureus growth. This intriguing result
implies that slightly different mechanisms may be at work in
each case, and suggests that it may be possible to attain selec-
tive therapeutic treatment of a specific species. Furthermore, the
saturated series of analogues were demonstrated to inhibit the
production of pyocyanin by P. aeruginosa, a virulence factor
known to be under QS regulation, providing valuable new SAR
insights regarding N-substitution of PQS and HHQ analogues.
Supporting Information
Supporting Information File 1
Experimental procedures and analytical data.
[https://www.beilstein-journals.org/bjoc/content/
supplementary/1860-5397-14-245-S1.pdf]
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